Drug intelligence / Profile preview

claudin-1-IRDye800CW

Development stage
Preclinical
Lead developer
University of California, San Diego
Modality
Antibody-Based Therapeutics
Administration
Intravenous
01

Overview

claudin-1-IRDye800CW is a near-infrared (NIR) fluorescence imaging agent consisting of a monoclonal antibody targeting Claudin-1 conjugated to the NIR fluorophore IRDye800CW. Claudin-1 is a tight-junction protein that is frequently overexpressed in colorectal cancer (CRC) and its metastases, while having limited expression in normal tissues, making it an ideal target for molecular imaging. This conjugate is designed to provide high-contrast visualization of primary tumors and sub-millimeter metastases during fluorescence-guided surgery. In preclinical models, it has demonstrated the ability to delineate tumor margins with high tumor-to-background ratios, facilitating real-time intraoperative detection using clinical laparoscopic platforms.

Other names
anti-Claudin-1-IRDye800CWanti-Claudin1-IRDye800CWanti-Claudin 1-IRDye800CWClaudin-1-targeted NIR fluorescence imaging probeClaudin1-targeted NIR fluorescence imaging probeClaudin 1-targeted NIR fluorescence imaging probe
02

Targets

CLDN1 (Tight junction protein claudin-1)

Beyond the preview

Go deeper on claudin-1-IRDye800CW.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on claudin-1-IRDye800CW.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call